Model-based dose escalation designs used in early-phase 1 trials to assess safety and tolerability of immuno-oncology therapies. Issue 3 (2020)

Record Type:: Journal Article
Title:: Model-based dose escalation designs used in early-phase 1 trials to assess safety and tolerability of immuno-oncology therapies. Issue 3 (2020)
Main Title:: Model-based dose escalation designs used in early-phase 1 trials to assess safety and tolerability of immuno-oncology therapies
Authors:: Adessi, Céline
Michielin, Francesca
Is Part Of:: Immuno-oncology insights. Volume 1:Issue 3(2020)
Journal:: Immuno-oncology insights
Issue:: Volume 1:Issue 3(2020)
Issue Display:: Volume 1, Issue 3 (2020)
Year:: 2020
Volume:: 1
Issue:: 3
Issue Sort Value:: 2020-0001-0003-0000
Page Start:
Page End:
Publication Date:: 2020
Subjects:: Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
616.99406105
Journal URLs:: https://www.insights.bio/immuno-oncology-insights/journal ↗
DOI:: 10.18609/ioi.2020.020 ↗
Languages:: English
ISSNs:: 2634-5099
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 14995.xml